| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8419254 | Journal of Immunological Methods | 2011 | 10 Pages |
Abstract
⺠The endocannabinoid 2-AG is a major residual lipid in commercial FBS. ⺠2-AG in FBS can induce significant cellular activation of primary monocytes/macrophages and increase RANKL-stimulated osteoclastogenesis. ⺠LPS-stimulated U937 cells show differential IL-6 expression depending on FBS batch. ⺠Polymyxin B beads bind to and selectively remove 2-AG.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biotechnology
Authors
Janine Marazzi, Jonas Kleyer, Juan Manuel Viveros Paredes, Jürg Gertsch,